Mice with neonatally induced inactivation of the vascular cell adhesion molecule-1 fail to control the parasite in Toxoplasma encephalitis

European Journal of Immunology

Volumn 33, Issue 5, 2003, Pages 1418-1428

  Deckert, Martina ^a   Lütjen, Sonja ^a,b   Leuker, Christoph E ^a   Kwok, Lai Yu ^b   Strack, Andreas ^a   Müller, Werner ^a,c   Wagner, Norbert ^a,d   Schluter D ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d KLINIKUM DORTMUND   (Germany)

Author keywords

B cell; Macrophage; T cell; T. gondii; VCAM 1

Indexed keywords

CELL ADHESION MOLECULE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; BRAIN BLOOD VESSEL; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; CONTROLLED STUDY; ENCEPHALITIS; EPENDYMA; EPITHELIUM CELL; GENE FREQUENCY; GENE INACTIVATION; GENE INDUCTION; IMMUNITY; LEUKOCYTE; LYMPHOCYTE HOMING; MICROGLIA; MOUSE; NONHUMAN; PARASITE CONTROL; PRIORITY JOURNAL; TOXOPLASMA; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, PROTOZOAN; CHRONIC DISEASE; ENCEPHALITIS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, CEREBRAL; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0037621613     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200322826     Document Type: Article

References (48)

1. Kamata, T., Puzon, W. and Takada, Y., Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29). Biochem. J. 1995. 305: 945-951.
2. Elices, M. J., Osborn, L., Takada, Y., Crouse, C., Luhowskyj, S., Hemler, M. E. and Lobb, R. R., VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990. 60: 577-584.
3. Ruegg, C., Postigo, A. A., Silkorski, E. E., Butcher, E. C., Pytela, R. and Erle, D. J., Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering. J. Cell Biol. 1992. 117: 179-189.
4. Steffen, B. J., Breier, G., Butcher, E. C., Schulz, M. and Engelhardt, B., ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am. J. Pathol. 1996. 148: 1819-1838.
5. Deckert-Schlüter, M., Schlüter, D., Hof, H., Wiestler, O. D. and Lassmann, H., Differential expression of ICAM-1, VCAM-1 and their ligands LFA-1, Mac-1, CD43, VLA-4, and MHC class II antigens in murine Toxoplasma encephalitis: a light microscopic and ultrastructural immunohistochemical study. J. Neuropathol. Exp. Neurol. 1994. 53: 457-468.
6. Dopp, J. M., Breneman, S. M. and Olschowka, J. A., Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis. J. Neuroimmunol. 1994. 54: 129-144.
7. Laschinger, M. and Engelhardt, B., Interaction of alpha 4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J. Neuroimmunol. 2000. 102: 32-43.
8. Wong, D., Prameya, R. and Dorovini-Zis, K., In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 1999. 58: 138-152.
9. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L. and Karin, N., Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992. 356: 63-66.
10. Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G. and Janeway, C. A. Jr., Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 1993. 177: 57-68.
11. Engelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D. and Hoch, G., The development of experimental autoimmune encephalomyelitis in the mouse requires alpha 4-integrin but not alpha 4 beta 7-integrin. J. Clin. Invest. 1998. 102: 2096-2105.
12. Barten, D. M. and Ruddle, N. H., Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 1994. 51: 123-133.
13. Male, D., Pryce, G., Linke, A. and Rahman, J., Lymphocyte migration into the CNS modelled in vitro. J. Neuroimmunol. 1992. 40: 167-171.
14. Freedman, A. S., Munro, J. M., Rice, G. E., Bevilacqua, M. P., Morimoto, C., McIntyre, B. W., Rhynhart, K., Pober, J. S. and Nadler, L. M., Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. Science 1990. 249: 1030-1033.
15. Koopman, G., Parmentier, H. K., Schuurman, H. J., Newman, W., Meijer, C. J. and Pals, S. T., Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J. Exp. Med. 1991. 173: 1297-1304.
16. Miyake, K., Medina, K., Ishihara, K., Kimoto, M., Auerbach, R. and Kincade, P. W., A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J. Cell Biol. 1991. 114: 557-565.
17. Papayannopoulou, T. and Nakamoto, B., Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc. Natl. Acad. Sci. U S A 1993. 90: 9374-9378.
18. Papayannopoulou, T., Craddock, C., Nakamoto, B., Priestley, G. V. and Wolf, N. S., The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc. Natl. Acad. Sci. U S A 1995. 92: 9647-9651.
19. Craddock, C. F., Nakamoto, B., Elices, M. and Papayannopoulou, T., The role of CS1 moiety of fibronectin in VLA mediated haemopoietic progenitor trafficking. Br. J. Haematol. 1997. 97: 15-21.
20. Leuker, C. E., Labow, M., Muller, W. and Wagner, N., Neonatally induced inactivation of the vascular cell adhesion molecule gene impairs B cell localization and T cell-dependent human immune response. J. Exp. Med. 2001. 193: 755-768.
21. Koni, P. A., Joshi, S. K., Temann, U. A., Olson, D., Burkly, L. and Flavell, R. A., Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 2001. 193: 741-754.
22. Koopman, G., Keehnen, R. M., Lindhout, E., Newman, W., Shimizu, Y., van Seventer, G. A., de Groot, C. and Pals, S. T., Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J. Immunol. 1994. 152: 3760-3767.
23. Koopman, G., Keehnen, R. M., Lindhout, E., Zhou, D. F., de Groot, C. and Pals, S. T., Germinal center B cells rescued from apoptosis by CD40 ligation or attachment to follicular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD95-induced apoptosis. Eur. J. Immunol. 1997. 27: 1-7.
24. Burkly, L. C., Jakubowski, A., Newman, B. M., Rosa, M. D., Chi-Rosso, G. and Lobb, R. R., Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation. Eur. J. Immunol. 1991. 21: 2871-2875.
25. Damle, N. K., Klussman, K., Linsley, P. S. and Aruffo, A., Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J. Immunol. 1992. 148: 1985-1992.
26. Schlegel, P. G., Vaysburd, M., Chen, Y., Butcher, E. C. and Chao, N. J., Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers. J. Immunol. 1995. 155: 3856-3865.
27. Gazzinelli, R. T., Hakim, F. T., Hieny, S., Shearer, G. M. and Sher, A., Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 1991. 146: 286-292.
28. Gazzinelli, R., Xu, Y., Hieny, S., Cheever, A. and Sher, A., Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gandii. J. Immunol. 1992. 149: 175-180.
29. Schlüter, D., Lohler, J., Deckert, M., Hof, H. and Schwendemann, G., Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. J. Neuroimmunol. 1991. 31: 185-198.
30. Schluter, D., Deckert-Schluter, M., Schwendemann, G., Brunner, H. and Hof, H., Expression of major histocompatibility complex class II antigens and levels of interferon-gamma, tumour necrosis factor, and interleukin-6 in cerebrospinal fluid and serum in Toxoplasma gondii-infected SCID and immunocompetent C.B-17 mice. Immunology 1993. 78: 430-435.
31. Sayles, P. C., Gibson, G. W. and Johnson, L. L., B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect. Immun. 2000. 68: 1026-1033.
32. Kang, H., Remington, J. S. and Suzuki, Y., Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J. Immunol. 2000. 164: 2629-2634.
33. Suzuki, Y. and Remington, J. S., Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J. Immunol. 1988. 140: 3943-3946.
34. Suzuki, Y., Orellana, M. A., Schreiber, R. D. and Remington, J. S., Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988. 240: 516-518.
35. Deckert-Schlüter, M., Rang, A., Weiner, D., Huang, S., Wiestler, O. D., Hof, H. and Schlüter, D., Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab. Invest. 1996. 75: 827-841.
36. Gazzinelli, R. T., Eltoum, I., Wynn, T. A. and Sher, A., Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 1993. 151: 3672-3681.
37. Scharton-Kersten, T. M., Wynn, T. A., Denkers, E. Y., Bala, S., Grunvald, E., Hieny, S., Gazzinelli, R. T. and Sher, A., In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 1996. 157: 4045-4054.
38. Scharton-Kersten, T. M., Yap, G., Magram, J. and Sher, A., Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 1997. 185: 1261-1273.
39. Yap, G. S., Scharton-Kersten, T, Charest, H. and Sher, A., Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 1998. 160: 1340-1345.
40. Schlüter, D., Deckert-Schlüter, M., Lorenz, E., Meyer, T., Röllinghoff, M. and Bogdan, C., Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T gondii-resistant BALB/c mice. J. Immunol. 1999. 162: 3512-3518.
41. Schlüter, D., Meyer, T., Strack, A., Reiter, S., Kretschmar, M., Wiestler, O. D., Hof, H. and Deckert, M., Regulation of microglia by CD4+ and CD8+ T cells: selective analysis in CD45-congenic normal and Toxoplasma gondii-infected bone marrow chimeras. Brain Pathol. 2001. 11: 44-55.
42. Johnson, L. L. and Sayles, P. C., Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect. Immun. 2002. 70: 185-191.
43. Schlüter, D., Meyer, T., Kwok, L. Y., Montesinos-Rongen, M., Lutjen, S., Strack, A., Schmitz, M. L. and Deckert, M., Phenotype and regulation of persistent intracerebral T cells in murine Toxoplasma encephalitis. J. Immunol. 2002. 169: 315-322.
44. Hochman, J., Assaf, N., Deckert-Schlüter, M., Wiestler, O. D. and Pe'er, J., Entry routes of malignant lymphoma into the brain and eyes in a mouse model. Cancer Res. 2001. 61: 5242-5247.
45. Assaf, N., Hasson, T., Hoch-Marchaim, H., Pe'er, J., Gnessin, H., Deckert-Schlüter, M., Wiestler, O. D. and Hochman, J., An experimental model for infiltration of malignant lymphoma to the eye and brain. Virchows Arch. 1997. 431: 459-467.
46. Schlüter, D., Kaefer, N., Hof, H., Wiestler, O. D. and Deckert-Schlüter, M., Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am. J. Pathol. 1997. 150: 1021-1035.
47. Hahne, M., Lenter, M., Jager, U., Isenmann, S. and Vestweber, D., VCAM-1 is not involved in LPAM-1 (alpha 4 beta p/alpha 4 beta 7) mediated binding of lymphoma cells to high endothelial venules of mucosa-associated lymph nodes. Eur. J. Cell Biol. 1993. 61: 290-298.
48. Vajkoczy, P., Laschinger, M. and Engelhardt, B., Alpha 4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 2001. 108: 557-565.